High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice

Prostate

Volumn 74, Issue 13, 2014, Pages 1266-1277

  Chang, Seo Na ^a   Han, Juhee ^a   Abdelkader, Tamer Said ^a   Kim, Tae Hyoun ^a   Lee, Ji Min ^a   Song, Juha ^a   Kim, Kyung Sul ^a   Park, Jong Hwan ^b   Park, Jae Hak ^a  

^a Seoul National University   (South Korea)

^b Konyang University   (South Korea)

Author keywords

cholesterol; GPx3; high fat diet; prostate cancer; TRAMP

Indexed keywords

CHOLESTEROL; GPX3; HIGH-FAT DIET; PROSTATE CANCER; TRAMP;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DIET, HIGH-FAT; DISEASE PROGRESSION; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MALE; MICE; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84905912405     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22843     Document Type: Article

References (39)

1. Lin DW, Porter M, Montgomery B,. Treatment and survival outcomes in young men diagnosed with prostate cancer: A population-based cohort study. Cancer 2009; 115 (13): 2863-2871.
2. Welch HG, Albertsen PC,. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101 (19): 1325-1329.
3. Lemarchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T,. Animal fat consumption and prostate-cancer-A prospective-study in Hawaii. Epidemiology 1994; 5 (3): 276-282.
4. Lophatananon A, Archer J, Easton D, Pocock R, Dearnaley D, Guy M, Kote-Jarai Z, O'Brien L, Wilkinson RA, Hall AL, Sawyer E, Page E, Liu JF, Barratt S, Rahman AA, Eeles R, Muir K, Col UGPCS, Sect BAUS,. Dietary fat and early-onset prostate cancer risk. Br J Nutr 2010; 103 (9): 1375-1380.
5. Rohrmann S, Roberts WW, Walsh PC, Platz EA,. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 2003; 55 (2): 140-146.
6. Gong ZH, Agalliu I, Lin DW, Stanford JL, Kristal AR,. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-Aged men. Cancer 2007; 109 (6): 1192-1202.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61 (2): 69-90.
8. Bray F, Ren JS, Masuyer E, Ferlay J,. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132 (5): 1133-1145.
9. Zhang JJ, Dhakal IB, Zhao ZJ, Li L,. Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: Role of nutrition transition. Eur J Cancer Prev 2012; 21 (5): 480-489.
10. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM,. Cancers of the prostate and breast among Japanese and white immigrants in Los-Angeles-County. Br J Cancer 1991; 63 (6): 963-966.
11. Cook LS, Goldoft M, Schwartz SM, Weiss NS,. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999; 161 (1): 152-155.
12. Gronberg H,. Prostate cancer epidemiology. Lancet 2003; 361 (9360): 859-864.
13. Klassen AC, Platz EA,. What can geography tell us about prostate cancer ? Am J Prev Med 2006; 30 (2): S7-S15.
14. Venkateswaran V, Klotz LH,. Diet and prostate cancer: Mechanisms of action and implications for chemoprevention. Nat Rev Urol 2010; 7 (8): 442-453.
15. Hori S, Butler E, McLoughlin J,. Prostate cancer and diet: Food for thought ? BJU Int 2011; 107 (9): 1348-1359.
16. Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG,. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 2010; 177 (6): 3180-3191.
17. Rao AV, Fleshner N, Agarwal S,. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutr Cancer 1999; 33 (2): 159-164.
18. Takahashi K, Avissar N, Whitin J, Cohen H,. Purification and characterization of human plasma glutathione peroxidase: A selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys 1987; 256 (2): 677-686.
19. Zhang X, Yang JJ, Kim YS, Kim KY, Ahn WS, Yang S,. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int J Oncol 2010; 36 (2): 405-414.
20. Murawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, Tanida O, Kohno M, Mukoyama T, Nishimuki E, Kojo H, Matsura T, Takahashi K, Osaki M, Ito H, Yodoi J, Murawaki Y, Shiota G,. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2008; 259 (2): 218-230.
21. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H,. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 2005; 65 (10): 4218-4227.
22. Yu YP, Yu GY, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH,. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67 (17): 8043-8050.
23. Chen BS, Rao X, House MG, Nephew KP, Cullen KJ, Guo ZM,. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett 2011; 309 (1): 37-45.
24. Sekine Y, Osei-Hwedieh D, Matsuda K, Raghavachari N, Liu DL, Furuya Y, Koike H, Suzuki K, Remaley AT,. High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate. Prostate 2011; 71 (14): 1499-1509.
25. Scholtysek C, Krukiewicz AA, Alonso JL, Sharma KP, Sharma PC, Goldmann WH,. Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction. Biochem Biophys Res Commun 2009; 379 (3): 795-798.
26. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25 (4): 402-408.
27. Park J-H, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, Cardiff RD,. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002; 161 (2): 727-735.
28. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM,. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996; 56 (18): 4096-4102.
29. Greenberg NM, Demayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM,. Prostate-cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92 (8): 3439-3443.
30. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM,. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003; 55 (3): 219-237.
31. Park SH, Chang SN, Baek MW, Kim DJ, Na YR, Seok SH, Lee BH, Kim KS, Park JH,. Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP mice. Lab Anim Res 2013; 29 (1): 39-47.
32. Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG,. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-Correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005; 103 (10): 2189-2198.
33. Bosaeus I, Daneryd P, Svanberg E, Lundholm K,. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001; 93 (3): 380-383.
34. Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, Williams CS,. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-Associated carcinoma. Cancer Res 2013; 73 (3): 1245-1255.
35. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR,. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8 (9): 2912-2923.
36. Grommes C, Landreth GE, Heneka MT,. Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists. Lancet Oncol 2004; 5 (7): 419-429.
37. Weng J, Chen C, Pinzone J, Ringel M, Chen C,. Beyond peroxisome proliferator-Activated receptor γ signaling: The multi-facets of the antitumor effect of thiazolidinediones. Endocr Relat Cancer 2006; 13 (2): 401-413.
38. Sikka S, Chen L, Sethi G, Kumar AP,. Targeting PPARγ signaling cascade for the prevention and treatment of prostate cancer. PPAR Res 2012; 2012: 968040.
39. Chung SS, Kim M, Youn B-S, Lee NS, Park JW, Lee IK, Lee YS, Kim JB, Cho YM, Lee HK,. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-Activated receptor γ in human skeletal muscle cells. Mol Cell Biol 2009; 29 (1): 20-30.